Blonder Tongue Laboratories Inc (BDRLQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,248 | -2,117 | -2,920 | 84 | -7,474 |
| Depreciation Amortization | 845 | 842 | 1,014 | 1,309 | 1,101 |
| Accounts receivable | 4 | 1,851 | -1,600 | 11 | 516 |
| Other Working Capital | 1,220 | 2,762 | -615 | -1,667 | 2,333 |
| Other Operating Activity | 218 | -1,349 | 2,739 | -904 | 312 |
| Operating Cash Flow | $1,039 | $1,989 | $-1,382 | $-1,167 | $-3,212 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -641 | -48 | -31 | -165 |
| Purchase Sale Intangibles | -7 | -6 | -7 | -55 | -26 |
| Other Investing Activity | -3 | -6 | -7 | -55 | -26 |
| Investing Cash Flow | $-7 | $-647 | $-55 | $-86 | $-191 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -473 | -1,458 | 1,987 | 255 | -560 |
| Debt Issued | N/A | N/A | N/A | 700 | 2,669 |
| Debt Repayment | -244 | 45 | -67 | -61 | -34 |
| Common Stock Issued | N/A | N/A | N/A | 564 | 825 |
| Other Financing Activity | -290 | 0 | -678 | 0 | 0 |
| Financing Cash Flow | $-1,007 | $-1,413 | $1,242 | $1,458 | $2,900 |
| Beginning Cash Position | 8 | 79 | 274 | 69 | 572 |
| End Cash Position | 33 | 8 | 79 | 274 | 69 |
| Net Cash Flow | $25 | $-71 | $-195 | $205 | $-503 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,039 | 1,989 | -1,382 | -1,167 | -3,212 |
| Capital Expenditure | -4 | -641 | -48 | -31 | -165 |
| Free Cash Flow | 1,035 | 1,348 | -1,430 | -1,198 | -3,377 |